Bronchial Artery Embolisation

Bronchial Artery Embolisation

Bronchial artery embolisation (BAE) is a minimally invasive medical procedure used primarily to control and treat life-threatening bleeding from the lungs, known as hemoptysis. Hemoptysis can range from mild to massive and can be a symptom of various underlying lung diseases. BAE has become an essential therapeutic option because it offers a targeted, effective, and less invasive alternative to surgery for controlling bleeding. Understanding BAE is important for patients, caregivers, and healthcare professionals as it can be a lifesaving intervention in critical respiratory conditions.

Anatomy / Background

The bronchial arteries are part of the systemic circulation and supply oxygenated blood to the lungs, airways, and supporting structures. Unlike the pulmonary arteries, which carry deoxygenated blood to the lungs for oxygenation, bronchial arteries nourish the lung tissue itself. Typically, there are one to two bronchial arteries on each side, originating from the thoracic aorta or intercostal arteries.

In certain pathological conditions, these arteries can become enlarged, tortuous, and fragile, leading to bleeding. Because the bronchial arteries are under systemic pressure, bleeding from these vessels can be severe and difficult to control. Understanding the anatomy of bronchial arteries is crucial for performing embolisation safely and effectively.

Causes / Etiology

Hemoptysis requiring bronchial artery embolisation can arise from various causes, including:

  • Chronic inflammatory lung diseases: Tuberculosis, bronchiectasis, cystic fibrosis, and chronic bronchitis can cause chronic inflammation and neovascularisation of bronchial arteries.
  • Malignancies: Lung cancer or metastatic tumors can erode blood vessels, leading to bleeding.
  • Vascular abnormalities: Arteriovenous malformations or aneurysms in bronchial arteries.
  • Trauma: Injury to the chest or lungs can damage bronchial arteries.
  • Idiopathic causes: In some cases, no clear cause is identified.

Symptoms / Clinical Presentation

The hallmark symptom prompting consideration of BAE is hemoptysis, which can present as:

Other associated symptoms may include cough, shortness of breath, chest pain, and signs of anemia if bleeding is prolonged.

Diagnosis

Diagnosing the cause and source of hemoptysis involves:

  • Clinical evaluation: Detailed history and physical examination focusing on respiratory and cardiovascular systems.
  • Imaging studies:
    • Chest X-ray: Initial screening to identify lung abnormalities.
    • Computed Tomography (CT) scan: High-resolution CT or CT angiography helps localize bleeding, identify underlying pathology, and visualize bronchial artery anatomy.
  • Bronchoscopy: Direct visualization of the airways to locate bleeding sites and sometimes provide therapeutic intervention.
  • Laboratory tests: Complete blood count, coagulation profile, and sputum analysis to assess bleeding severity and underlying infection.

Treatment Options

Treatment depends on the severity of hemoptysis and underlying cause:

Procedure Details

Bronchial artery embolisation is performed by an interventional radiologist under local anesthesia and sedation:

  1. Vascular access: Usually via the femoral artery using a catheter.
  2. Angiography: Contrast dye is injected to visualize bronchial arteries and identify bleeding vessels.
  3. Selective catheterization: The catheter is advanced into the culprit bronchial artery.
  4. Embolic agent delivery: Particles, coils, or glue are injected to occlude the bleeding artery, stopping blood flow.
  5. Post-embolisation angiography: Confirms successful occlusion and absence of non-target embolisation.

The procedure typically lasts 1-2 hours and patients are monitored closely afterward.

Postoperative Care / Rehabilitation

After BAE:

Risks and Complications

While BAE is generally safe, potential risks include:

    • Non-target embolisation: Accidental blockage of arteries supplying the spinal cord or other organs, leading to neurological deficits.
    • Chest pain or dysphagia: Due to ischemia of adjacent tissues.
    • Allergic reactions: To contrast dye.
    • Vascular injury: Including arterial dissection or hematoma at the access site.
    • Recurrence of hemoptysis: Due to revascularisation or new bleeding sites.

Prognosis

BAE has a high initial success rate (70-90%) in controlling hemoptysis. However, recurrence can occur in 10-30% of cases, often requiring repeat embolisation or surgery. Early intervention improves survival and reduces complications associated with massive hemoptysis.

When to See a Doctor

Seek immediate medical attention if you experience:

  • Coughing up blood, especially if it is moderate to large amounts.
  • Shortness of breath or chest pain accompanying hemoptysis.
  • Signs of anemia such as fatigue, dizziness, or palpitations.
  • Recurrent respiratory infections or worsening lung symptoms.

Early evaluation can prevent life-threatening complications.

Conclusion

Bronchial artery embolisation is a vital, minimally invasive procedure for managing severe hemoptysis. Understanding its indications, procedure, and potential risks empowers patients and healthcare providers to make informed decisions. If you or a loved one experiences significant lung bleeding, prompt consultation with a healthcare professional specializing in respiratory or interventional radiology is essential for optimal outcomes.

Welcome to
Dr Sahaja Vascular Surgeon

Aenean porta orci nam commodo felis hac ridiculus fusce fames maximus erat sed dictumst blandit arcu suspendisse sollicitudin luctus in nec

Make an Appointment.